ENZND — Enzon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

FinancialsSpeculativeMicro CapNeutral

Annual balance sheet for Enzon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	47.6	47	47	46.9	42.6
Net Total Accounts Receivable
Net Total Receivables	0.028	0	—	—	—
Total Other Current Assets
Total Current Assets	47.8	47.4	47.3	47.2	42.8
Other Long Term Assets
Total Assets	47.8	47.6	47.7	47.2	42.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.403	1.7	1.71	1.68	0.731
Total Long Term Debt
Total Debt
Total Liabilities	0.403	1.7	1.71	1.68	0.731
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	47.4	45.9	46	45.5	42.1
Total Liabilities & Shareholders' Equity	47.8	47.6	47.7	47.2	42.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding